The pathogenetic mechanism of the human mito- chondrial 128 rRNA gene mutat
ion at position 1555, associated with non-syndromic deafness and aminoglyco
side-induced deafness, has been investi gated in 33 transformants obtained
by transferring mitochondria from lymphoblastoid cell lines into human mito
chondrial DNA (mtDNA)-less (p degrees 206) cells. In this nearly constant n
uclear background, 15 transformants derived from five symptomatic individua
ls from a large Arab-israeli family, carrying this mutation in homoplasmic
form, exhibited significant decreases compared with nine control transforma
nts in the rate of growth in a medium containing galactose instead of gluco
se, as well as in the rates of mitochondrial protein synthesis and of subst
rate- dependent respiration. Most significantly, these decreases were very
similar to those observed in nine transformants derived from three asymptom
atic members of the family. This result in transmitochondrial cybrids is in
contrast to the differences in the same parameters previously demonstrated
between the original lymphoblastoid cell lines derived from symptomatic an
d asymptomatic members of the glycoside-induced deafness and non-syndromic
deafness Arab-Israeli family. In addition, the intragroup variability in bi
ochemical dysfunction among the lymphoblastoid cell lines from different sy
mptomatic or asymptomatic or control individuals was significantly reduced
in the derived mitochondrial transformants carrying the same nuclear backgr
ound. These observations provide strong genetic and biochemical evidence in
support of the idea that the nuclear background plays a determinant role i
n the phenotypic manifestation of the non-syndromic deafness associated wit
h the A1555G mutation.